Global Liquid Biopsy Market

Apr 2020| VMR277B| Verified Market Research

Report Highlights

Liquid Biopsy Market Size And Forecast

According to Verified Market Research, The Global Liquid Biopsy Market was valued at USD 1063.71 million in 2019 and is projected to reach USD 5027.46 million by 2027, growing at a CAGR of 23.12% from 2020 to 2027.

Global Liquid Biopsy Market Overview

With the advent of technological advancement in the healthcare sector, areas of medicine such as the diagnosis and treatment through progressive technology and minimally invasive procedures have therefore grown significantly as a result. With non-invasive or minimally invasive methods in general, there are several advantages as compared to its counterpart as it involves the drastic increase in overall patient safety as well as leads to enhanced customer satisfaction through decreasing or eliminating the overall patient recovery time.

On the other hand, the lack of skilled professionals and a lack of knowledge about liquid biopsy will pose a challenge to the growth of the market at a global level.

Liquid Biopsy Market Competetive Landscape:

Liquid Biopsy Market is highly fragmented with the presence of a large number of players globally. Some of the major companies include Biocept, Inc., Qiagen, F. Hoffmann-La Roche AG, Bio-Rad Laboratories Inc., Myriad Genetics, Janssen Diagnostics, LLC, Trovagene Inc., Guardant Health Inc., GRAIL, and MDX Health SA.

Verified Market Research has been providing Research Reports, with up to date information, and in-depth analysis, for several years now, to individuals and companies alike that are looking for accurate Research Data. It has large database which includes the latest content from renowned authors and publications worldwide. It also provides customized Data and Reports according to the need of the client.

Similar Reports from Verified Market Research

Global Liquid Biopsy Market

  • Date - Dec 2018
  • Code - VMR277A

Market Overview:
The global Liquid Biopsy Market was valued at USD 576.43 million in 2016 and is projected to reach USD 3747.18 million by 2025, growing at a CAGR of 23.12% from 2017 to 2025.

Liquid biopsy is a test done on a sample of blood to look for cancer cells from a tumor that are circulating in ...

Verified Market Research
Price: $3750

Become a Member

Already a member? Login to access this report free.

Have a Question? Ask Us.

Why BCC Research?

Every purchase provides access to:

  • Thousands of recently published reports from select publishers
  • Member Discounts of up to 50% on over 20,000 additional reports from all publishers
  • Our analysts and research concierge for all inquiries
CUSTOM RESEARCH

Need a custom data table, graph or complete report? Tell us more.

RELATED REPORTS
Share This Report